Trial · NCT03892577
Real-world Study for Patients With Advanced Hepatobiliary Tumors
NCT03892577, Unknown, Peking Union Medical College Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Real-world Study for Patients With Advanced Hepatobiliary Tumors. Trials, record NCT03892577. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03892577
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Real-world Study for Patients With Advanced Hepatobiliary Tumors
- NCT number
- NCT03892577
- Status
- Unknown
- Enrollment
- 3,000 participants, estimated
- Lead sponsor
- Peking Union Medical College Hospital
- Conditions
- Objective Response Rate, Progression-free Survival, Overall Survival, Disease Control Rate, Duration of Response, Five-year Survival Rate, Quality of Life
- Interventions
- Precision oncology including targeted therapy and immunotherapy
- First posted
- 2019-03-27
- Last updated
- 2023-03-29
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Overall Survival (OS) | two years | Time from the date of initial treatment to death for any cause. |
| Primary | Progression-free Survival (PFS) | six months | A duration from the date of initial treatment with apatinib to disease progression (as defined by RECIST) or death. |
| Secondary | Objective Response Rate (ORR) | one year | Percentage of subjects with complete response and partial response. |
| Secondary | Disease Control Rate (DCR) | six months | Percentage of subjects with complete remission, partial remission, or stable disease during treatment or within 30 days of termination of test drug. |
| Secondary | Incidence of Treatment-Emergent Adverse Event | one year | Percentage of subjects who develop any adverse events (CTCAE 4.0). |
| Secondary | Quality of Life (QoL) after treatment | one year | The life quality of every subject will be assessed every 3 months according to the 45-item FACT-Hep questionnaire, which assesses generic HRQL concerns and disease-specific issues. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers29
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03892577
GET https://conductscience.org/api/trials/v1/NCT03892577/papers?page=2